Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia

Patrick D. Thornton, Alicja M. Gruszka-Westwood, Rifat A. Hamoudi, Shayne Atkinson, Pawel Kaczmarek, Ricardo M. Morilla, Benjamin L. Hilditch, Roger A'Hern, Estella Matutes, Daniel Catovsky

Research output: Contribution to journalArticlepeer-review


Abnormalities of TP53 in chronic lymphocytic leukaemia (CLL) correlate with aggressive disease and transformation. We studied 115 patients with CLL including 90 untreated, 25 with heavily pretreated/refractory CLL using fluorescent in situ hybridisation (FISH) to detect allelic loss at chromosome 17p and flow cytometry (FC) to test p53 protein overexpression. A total of 17 cases were identified with TP53 deletion and/or protein expression. Both tests correlated in 10 of 17 patients; in six, one or the other abnormality was detected and in one case, with a deletion, flow cytometry failed. Material for direct DNA sequencing was available in 14 of 17 cases. Mutations were found in seven cases. Five of 14 patients with allelic loss and seven of 13 expressing p53 protein had a mutation. These were single-base substitutions and were located in exons 5, 7 or 8. Mutations were not found in 13 of 14 other cases without deletions by FISH or protein expression. The incidence of p53 abnormalities in this series was 15%, with a significant difference between untreated patients (7%) and the pretreated/refractory group (50%; P

Original languageEnglish
Pages (from-to)47-54
Number of pages8
JournalHematology Journal
Issue number1
Publication statusPublished - 2004


  • CLL
  • P53
  • Therapy
  • TP53

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia'. Together they form a unique fingerprint.

Cite this